Search results
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Short Interest Up 11.1% in May
ETF DAILY NEWS· 4 days agoArcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Get Free Report) was the recipient of a significant growth in short interest in the month of May. As of May 31st, there was short interest totalling ...
Johnson & Johnson submits application to U.S. FDA seeking approval of TREMFYA® (guselkumab) for the ...
Morningstar· 3 days agoFood and Drug Administration (FDA) seeking approval of TREMFYA® (guselkumab) for the treatment of adults with moderately to severely active Crohn's disease. The submission ...
J&J (JNJ) Seeks Expanded Use of Tremfya for Crohn's Disease
Zacks· 2 days agoJ&J (JNJ) seeks label expansion for Tremfya for treating moderately to severely active Crohn's disease. This marks the second sBLA filing for Tremfya in three months.
AbbVie (NYSE:ABBV) Given New $190.00 Price Target at Piper Sandler
ETF DAILY NEWS· 5 days agoAbbVie (NYSE:ABBV – Get Free Report) had its price objective boosted by research analysts at Piper Sandler from $185.00 to $190.00 in a research note issued on Tuesday, Benzinga reports. Piper ...
AbbVie's (ABBV) Skyrizi Gets FDA Nod for Ulcerative Colitis
Zacks· 4 days agoSkyrizi’s approval for the UC indication was based on data from two phase III studies, a 12-week induction study, INSPIRE1 and a 52-week maintenance study, COMMAND2. Skyrizi is already approved ...
AbbVie stock price forecast: $200 on the cards? | Invezz
Invezz· 3 days agoThis approval is a significant milestone, making Skyrizi now available for four different conditions in the U.S., including psoriatic arthritis, plaque psoriasis& ...
Amgen Inc. (NASDAQ:AMGN) Sees Significant Drop in Short Interest
ETF DAILY NEWS· 6 days agoAmgen Inc. (NASDAQ:AMGN – Get Free Report) was the recipient of a large decrease in short interest in May. As of May 31st, there was short interest totalling 9,050,000 shares, a decrease of ...
Gerber LLC Makes New $342,000 Investment in Amgen Inc. (NASDAQ:AMGN)
ETF DAILY NEWS· 6 days agoGerber LLC bought a new stake in Amgen Inc. (NASDAQ:AMGN – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission ...
Spartan Planning & Wealth Management Sells 194 Shares of Amgen Inc. (NASDAQ:AMGN)
ETF DAILY NEWS· 6 days agoSpartan Planning & Wealth Management cut its position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 15.3% in the fourth quarter, according to the company in its most recent disclosure ...
MONECO Advisors LLC Decreases Stock Holdings in Amgen Inc. (NASDAQ:AMGN)
ETF DAILY NEWS· 5 days agoMONECO Advisors LLC trimmed its holdings in Amgen Inc. (NASDAQ:AMGN – Free Report) by 11.2% during the fourth quarter, HoldingsChannel reports. The firm owned 1,741 shares of the medical research ...